View of NEOADJUVANT TRASTUZUMAB, WITH OR WITHOUT PERTUZUMAB, COMBINED WITH CHEMOTHERAPY FOR EARLY HER2-POSITIVE BREAST CANCER: A REAL-WORLD EXPERIENCE FROM A TERTIARY CANCER CENTRE

Return to Article Details NEOADJUVANT TRASTUZUMAB, WITH OR WITHOUT PERTUZUMAB, COMBINED WITH CHEMOTHERAPY FOR EARLY HER2-POSITIVE BREAST CANCER: A REAL-WORLD EXPERIENCE FROM A TERTIARY CANCER CENTRE Download Download PDF